2-Hydroxy-10-methyldecalin | 2547-28-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-Hydroxy-10-methyldecalin
• 英文别名: 4a-Methyldecahydronaphthalen-2-ol；4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1H-naphthalen-2-ol
• CAS: 2547-28-6
• 化学式: C₁₁H₂₀O
• 分子量: 168.279
• InChiKey: ZGVYVWSAAMJYCN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4A-甲基-4,4a,5,6,7,8-六氢-3H-萘-2-酮 在 四甲基乙二胺 、 tetrabutylammonium borohydride 作用下， 以 四氢呋喃 为溶剂， 反应 20.0h， 以100%的产率得到2-Hydroxy-10-methyldecalin
  参考文献：
  名称：

  硼氢化物的多环芳烃的选择性还原：四甲基乙二胺或四丁基铵的硼氢化物的有效添加

  摘要：

  • NBu 4 BH 4还原了1,9 octalone，‡ 1,9 -10-methyl octalone和睾丸激素。单独或在四甲基乙二胺（TMEDA）存在下，在THF和甲苯中使用。对于TMEDA，还原的第一步是由BH - 4进行的区域选择性1,4进攻，这可能导致饱和酮或相应的饱和醇。在不同条件下观察到的结果可以通过多种还原性物质的干预来解释：乙硼烷，在没有TMEDA的情况下的环氧烷硼化物，在其存在下的胺-硼烷。

  DOI：

  10.1016/0040-4020(82)85020-5

文献信息

• [B]-fused bicyclic proline derivatives and their use for treating arthritic conditions
  申请人：Barvian C. Nicole

  公开号：US20050143427A1

  公开（公告）日：2005-06-30

  This invention relates to a compound which is [b]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [b]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [b]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.

  本发明涉及一种[b]-融合的双环脯氨酸衍生物，或其药学上可接受的盐；包括该化合物或其盐的制药组合物，以及治疗疾病的方法，包括但不限于预防或抑制关节软骨损伤和预防或治疗以关节软骨损伤、关节炎或关节疼痛为特征的疾病的方法。[b]-融合的双环脯氨酸衍生物是如上所述的式I的化合物。以关节软骨损伤或关节疼痛为特征的疾病包括骨关节炎和类风湿性关节炎等。类风湿性关节炎也以关节炎为特征。本发明还涉及合成和制备[b]-融合的双环脯氨酸衍生物或其药学上可接受的盐的方法。
• [C]-fused bicyclic proline derivatives and their use for treating arthritic conditions
  申请人：Guzzo R. Peter

  公开号：US20050137215A1

  公开（公告）日：2005-06-23

  This invention relates to a compound which is [c]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [c]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [c]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.

  本发明涉及一种[c]-融合的双环脯氨酸衍生物化合物或其药学上可接受的盐；一种包括该化合物或其盐的制药组合物，以及治疗疾病的方法，包括但不限于预防或抑制关节软骨损伤和预防或治疗以关节软骨损伤、关节炎或关节疼痛为特征的疾病的方法。[c]-融合的双环脯氨酸衍生物是如上所述的化合物I。以关节软骨损伤或关节疼痛为特征的疾病包括骨关节炎和类风湿性关节炎等。类风湿性关节炎还表现为关节炎。本发明还涉及合成和制备[c]-融合的双环脯氨酸衍生物或其药学上可接受的盐的方法。
• N-Nitroaziridines: synthesis, thermal stability, and solvolytic reactivity
  作者：Michael J. Haire、George A. Boswell

  DOI：10.1021/jo00862a017

  日期：1977.12